These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 24296169)

  • 1. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.
    ten Broeke T; Wubbolts R; Stoorvogel W
    Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a016873. PubMed ID: 24296169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.
    ten Broeke T; van Niel G; Wauben MH; Wubbolts R; Stoorvogel W
    Traffic; 2011 Aug; 12(8):1025-36. PubMed ID: 21518167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
    Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
    J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
    van Niel G; Wubbolts R; Stoorvogel W
    Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
    Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
    J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

  • 8. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
    Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
    J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal localization of MHC class II-invariant chain complexes.
    Miller J
    Immunol Res; 1994; 13(4):244-52. PubMed ID: 7616052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
    Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain is a new chaperone for TLR7 in B cells.
    Tohmé M; Manoury B
    Mol Immunol; 2015 Dec; 68(2 Pt A):102-5. PubMed ID: 26198699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane specializations and endosome maturation in dendritic cells and B cells.
    Boes M; Cuvillier A; Ploegh H
    Trends Cell Biol; 2004 Apr; 14(4):175-83. PubMed ID: 15066635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
    Perrin P; Jongsma ML; Neefjes J; Berlin I
    Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
    Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
    J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trafficking of MHC class II molecules in the late secretory pathway.
    Hiltbold EM; Roche PA
    Curr Opin Immunol; 2002 Feb; 14(1):30-5. PubMed ID: 11790530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
    Cho KJ; Ishido S; Eisenlohr LC; Roche PA
    J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
    Buschow SI; Nolte-'t Hoen EN; van Niel G; Pols MS; ten Broeke T; Lauwen M; Ossendorp F; Melief CJ; Raposo G; Wubbolts R; Wauben MH; Stoorvogel W
    Traffic; 2009 Oct; 10(10):1528-42. PubMed ID: 19682328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.